Anais Boisson

Brussels, BRU 1070, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative Review.

Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative Review.

Journal: Vaccines
Published: March 30, 2026

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.

Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.

Journal: Frontiers in immunology
Published: February 23, 2026

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

RAD51-based homologous recombination deficiency is associated with treatment response and survival in early breast cancer.

Journal: NPJ breast cancer
Published: July 31, 2025

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

Journal: British journal of cancer
Published: July 23, 2024

Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer.

Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer.

Journal: Cancers
Published: July 10, 2024

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma.

Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma.

Journal: Journal for immunotherapy of cancer
Published: December 13, 2023

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment.

Fluorescent Multiplex Immunohistochemistry Coupled With Other State-Of-The-Art Techniques to Systematically Characterize the Tumor Immune Microenvironment.

Journal: Frontiers in molecular biosciences
Published: February 26, 2021

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

Journal: The Journal of clinical investigation
Published: May 08, 2020

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Journal: JCI insight
Published: August 14, 2019

BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.

BRCA gene mutations do not shape the extent and organization of tumor infiltrating lymphocytes in triple negative breast cancer.

Journal: Cancer letters
Published: September 19, 2018

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

Journal: EBioMedicine
Published: September 12, 2018

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.

Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer.

Journal: Frontiers in immunology
Published: July 05, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026